Parliamentary Panel Urges Stricter FDI Scrutiny for Private Hospitals
Parliamentary panel calls for differentiated FDI policy: promote investment in medical devices and rare disease medicines, but scrutinise hospital acquisitions.
A parliamentary committee has recommended a differentiated approach to foreign direct investment (FDI) in India's healthcare sector, suggesting that capital inflows be welcomed in specific manufacturing segments while facing tighter oversight in hospital operations.
The Parliamentary Standing Committee on Health and Family Welfare has flagged concerns over what it describes as aggressive corporatisation in the private hospital space, warning that unchecked expansion could contribute to rising healthcare costs for patients.
In its report, the panel draws a clear distinction between various forms of foreign investment. It argues that FDI should be actively encouraged in the production of medical devices, consumables, and specialised medicines formulated for rare diseases. These areas, it notes, align with broader public health goals of improving access and reducing import dependence.
However, the committee has called for greater scrutiny when foreign capital is directed towards the direct operation of hospitals or the acquisition of existing healthcare facilities. The recommendation signals a policy preference for investment that strengthens manufacturing capabilities rather than expanding corporate ownership of clinical infrastructure.
The report's findings come amid ongoing debates about the balance between private sector participation and affordable healthcare delivery in India. The panel's stance suggests a need for regulatory guardrails to ensure that foreign investment serves public interest objectives without distorting the healthcare market.